Therapeutic spectrum of interferon‐β in ischemic stroke

Ischemic stroke is devastating and a major cause of morbidity and mortality worldwide. To date, only clot retrieval devices and/or intravenous tissue plasminogen activators (tPA) have been approved by the US‐FDA for the treatment of acute ischemic stroke. Therefore, there is an urgent need to develo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosci Res
Main Authors: Wanve, Madhuri, Kaur, Harpreet, Sarmah, Deepaneeta, Saraf, Jackson, Pravalika, Kanta, Vats, Kanchan, Kalia, Kiran, Borah, Anupom, Yavagal, Dileep R., Dave, Kunjan R., Bhattacharya, Pallab
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Minireviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7167007/
https://ncbi.nlm.nih.gov/pubmed/30320448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jnr.24333
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados